Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Burcon NutraScience Corp T.BU

Alternate Symbol(s):  BRCNF

Burcon NutraScience Corporation is a Canada-based technology company. The Company is engaged in the development of plant-based proteins for foods and beverages. The Company has a patent portfolio covering its specialty plant-based proteins derived from pea, canola, soy, hemp and sunflower seeds, among other plant sources. The Company is involved in the production, sales, marketing and distribution of pulse protein ingredients, including Peazazz and Peazac pea proteins and its canola proteins, Supertein, Puratein and Nutratein (collectively, the Products). The Company's subsidiary is Burcon NutraScience (MB) Corp., which is engaged in the research and development.


TSX:BU - Post by User

Post by Trendsetteron Feb 10, 2022 12:06pm
296 Views
Post# 34416947

Realistically its only a matter of time...

Realistically its only a matter of time...before Bunge takes out Merit and BU position in the plant because it WILL be a producing plant of high quality plant protein.   

Question1 is when!   Common sense would suggest that Bunge have to be aware of what the they have in terms of product quality and future demand...so why would they wait until phase 2 and 3 are underway?   

Question 2 is : Not knowing the sale price of product (though if we are to beleive the pathetically small ammount of information we have received that the product is best in class) it would be nice to see the various analysts following the company to provide a what if scenario analysis on what the facility sale price (by Merit and BU to Bunge) would be at phase 1 fully capacity output, if they waited until phase 2 competion and again at maximum phase 3 production.

If there are any smart minds still reading this mostly useless blog site out there, would anyone have a guess?
<< Previous
Bullboard Posts
Next >>